Document and Entity Information |
Mar. 31, 2022 |
|---|---|
| Cover [Abstract] | |
| Amendment Flag | false |
| Entity Central Index Key | 0001419041 |
| Document Type | 8-K |
| Document Period End Date | Mar. 31, 2022 |
| Entity Registrant Name | Forte Biosciences, Inc. |
| Entity Incorporation State Country Code | DE |
| Entity File Number | 001-38052 |
| Entity Tax Identification Number | 26-1243872 |
| Entity Address, Address Line One | 3060 Pegasus Park Drive |
| Entity Address, Address Line Two | Building 6 |
| Entity Address, City or Town | Dallas |
| Entity Address, State or Province | TX |
| Entity Address, Postal Zip Code | 75247 |
| City Area Code | (310) |
| Local Phone Number | 618-6994 |
| Written Communications | false |
| Soliciting Material | false |
| Pre Commencement Tender Offer | false |
| Pre Commencement Issuer Tender Offer | false |
| Security 12b Title | Common Stock, par value $0.001 per share |
| Trading Symbol | FBRX |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | true |